PsiOxus Therapeutics announces positive study results of oncolytic vaccine enadenotucirev at 2014 ASCO Annual Meeting

Mercia EIS Funds | 3rd June, 2014
PsiOxus Therapeutics announces positive study results of oncolytic vaccine enadenotucirev at 2014 ASCO Annual Meeting
Mercia EIS Funds | 27th May, 2014
PolyTherics and Antitope form Abzena
Mercia EIS Funds | 19th May, 2014
BioExtractions Wales completes funding round for innovative extraction service
Mercia EIS Funds | 14th May, 2014
Mercia Fund Management launches flexible, cost effective workspace for early stage gaming and technology businesses
Mercia EIS Funds | 12th May, 2014
Mercia Fund Management agrees second stage funding for VirtTrade
Mercia EIS Funds | 8th May, 2014
Mercia Fund Management backs social media duo Crowd Reactive and TorqBak
Mercia EIS Funds | 29th April, 2014
Thalia Design Automation Ltd completes A round funding and prepares to launch suite of Analog and Power design optimisation tools
Mercia EIS Funds | 25th April, 2014
Mercia Fund Management boosts portfolio with Canary investment
Mercia EIS Funds | 23rd April, 2014
Mercia mention in FT.com “Getting exposure to UK tech”
Mercia EIS Funds | 11th April, 2014
PolyTherics and MacroGenics extend Collaboration to Produce Novel Antibody Drug Conjugates